Turning Point Therapeutics, Inc.
TPTX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$236,551 | -$157,292 | -$72,131 | -$24,785 |
| Dep. & Amort. | $3,967 | $2,393 | $1,579 | $138 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $58,557 | $64,163 | $12,706 | $1,147 |
| Change in WC | $14,809 | $6,682 | $1,446 | $7 |
| Other Non-Cash | $5,333 | $1,261 | -$1,357 | -$40 |
| Operating Cash Flow | -$153,885 | -$82,793 | -$57,757 | -$23,533 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,427 | -$1,264 | -$1,744 | -$302 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$439,230 | -$618,973 | -$432,173 | $0 |
| Inv. Sales/Matur. | $447,119 | $410,205 | $72,838 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $5,462 | -$210,032 | -$361,079 | -$302 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $24,004 | $785,469 | $365,995 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $24,004 | $798,738 | $365,995 | $79,831 |
| Financing Cash Flow | $24,004 | $798,738 | $365,995 | $79,831 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$124,419 | $505,913 | -$52,841 | $55,996 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $554,174 | $48,188 | $101,029 | $45,033 |
| End Cash | $429,755 | $554,101 | $48,188 | $101,029 |
| Free Cash Flow | -$156,312 | -$84,057 | -$59,501 | -$23,835 |